Effect of arsenic trioxide on human hepatocarcinoma in nude mice

World Journal of Gastroenterology

Volumn 10, Issue 24, 2004, Pages 3677-3679

  Xu, Hong Yu ^a   Yang, You Lin ^a   Liu, Shu Mei ^a   Bi, Li ^a   Chen, Shu Xiang ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; ARSENIC TRIOXIDE; FLUOROURACIL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER TRANSPLANTATION; CONTROLLED STUDY; DRUG MECHANISM; ELECTRON MICROSCOPY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INOCULATION; KIDNEY STRUCTURE; LIVER CELL CARCINOMA; LIVER STRUCTURE; MALE; MITOCHONDRION; MORPHOLOGY; MOUSE; NONHUMAN; NUDE MOUSE; PERITONEAL CAVITY; TUMOR CELL CULTURE; TUMOR CELL LINE; TUMOR VOLUME;

EID: 10244255101     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v10.i24.3677     Document Type: Article

References (15)

1. Zhang P, Wang SY, Hu LH, Shi FD, Qiu FQ, Hong LG, Han XY, Yang HF, Song YZ, Liu YP, Zhou J, Jing ZJ. Treatment of acute promyelocytic leukemia with intravenous arsenic trioxide. Zhonghua Xueyexue Zazhi 1996; 17: 58-60
2. Andre C, guillemin MC, Zhu J, Koken MH, Quignon F, Herve L, Chelbi Alix MK, Dhumeaasx D, Wang ZY, Degos L, Chen Z, De The H. The PML and PML/RA Ralpha domains from autoimmunity to molecular oncology and from retinoic acid to arsenic. Exp Cell Res 1996; 229: 253-260
3. Wang ZY. Development of arsenical clinical application and study of arsenical mechanism. Zhonghua Xueyexue Zazhi 1996; 17: 57
4. Shen ZX, Chen GQ, NI JH, Li XS, Xiong SM, Qin QY, Zhu J, Tang W, Sun GL, Yang KQ, Chen Y, Zhou L, Fang ZW, Wang YT, Zhang P, Zhang TD, Chen SJ, Chen Z, Wang ZY. Use of arsenic trioxide in the treatment of Acute promyelocytic leukemia II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood 1997; 89: 3354-3360
5. Konig A, Wraze L, Warrelll RP Jr, Rivi R, Pandolfi PP, Jakubowski A, Gabrilove JL. Comparative activity of melarsoprol and arsenic trioxide in chronic B-cell leukemia lines. Blood 1997; 90: 562-570
6. 3 Shanghai Dier Yikedaxue Xuebao 1999; 19: 5-8
7. Tu SP, Jiang SH, Tan JH, Jiang XH, Qiao MM, Zhang YP, Wu YL, Wu YX. Proliferation inhibition and apoptosis induction by arsenic trioxide on gastric cancer cell SGC-7901. Shijie Huaren Xiaohua Zazhi 1999; 7: 18-21
8. Chen HY, Liu WH, Qin SK. Induction of arsenic trioxide on apoptosis of hepatocarcinoma cell lines. Shijie Huaren Xiaohua Zazhi 2000; 8: 532-535
9. Guo WJ, Yu EX, Zheng SG, Shen ZZ, Luo JM, Wu GH, Xia SA. Study on the apoptosis and cell cycle arrest in human liver cancer SMMC7721 cells induced by Jianpiliqi herbs. Shijie Huaren Xiaohua Zazhi 2000; 8: 52-55
10. Shen YF, Zhuang H, Shen JW, Chen SB. Cell apoptosis and neoplasms. Shijie Huaren Xiaohua Zazhi 1999; 7: 267-268
11. Feng CQ, Ma WL, Zheng WL. Research advances on effect of arsenic trioxide on tumor. Aizheng 2002; 21: 1386-1389
12. Liu Q, Hilsenbeck S, Gazitt Y. Arsenic trioxide-induced apoptosis in myeloma cells: p53-dependent G1 or G2/M cell cycle arrest, activation of caspase-8 or caspase-9, and synergy with APO2/TRAIL. Blood 2003; 101: 4078-4087
13. Kanzawa T, Kondo Y, Ito H, Kondo S, Germano I. Induction of autophagic cel1 death in malignant glioma cells by arsenic trioxide. Cancer Res 2003; 63: 2103-2108
14. Huang SG, Kong BH, Yang RF, Jiang S. Primary study of arsenic trioxide inhibits abdomino-metastatic tumor formation of human ovarian carcinoma in nude mice and its mechanisms. Aizheng 2002; 21: 401-404
15. Yu D, Wang Z, Zhu L, Chew EC. Nuclear matrix associated protein PML: an arsenic trioxide apoptosis therapeutic target protein in HepG2 cells. Chin Med J 2003; 116: 93-98